News & Events June

Preliminary Results Presented at American Transplant Congress on Largest Ever Hepatitis C Trial Conducted in Liver Transplant Recipients

June 15, 2004

Early Data Shows Steroid-Free Protocol May Be Safe with Low Rejection Rates CTI Clinical Trial and Consulting Services announced that Goran Klintmalm, M.D., Ph.D., chief of Baylor Regional Transplant Institute and principle investigator of a study comparing 3 immunosuppressant treatment regimens in liver transplant recipients with hepatitis C, presented ...